Kenvue Inc. (KVUE)
NYSE: KVUE · Real-Time Price · USD
18.16
-0.23 (-1.25%)
At close: Mar 9, 2026, 4:00 PM EDT
18.15
-0.01 (-0.06%)
After-hours: Mar 9, 2026, 7:49 PM EDT

Company Description

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America.

It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women’s health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements.

It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee’s Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson’s, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson’s Baby, Johnson’s Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands.

Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Kenvue Inc.
Kenvue logo
Country United States
Founded 2022
IPO Date May 4, 2023
Industry Household & Personal Products
Sector Consumer Staples
Employees 22,000
CEO Kirk Perry

Contact Details

Address:
1 Kenvue Way
Summit, New Jersey 07901
United States
Phone 908-874-1200
Website kenvue.com

Stock Details

Ticker Symbol KVUE
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $22.00
CIK Code 0001944048
CUSIP Number 49177J102
ISIN Number US49177J1025
Employer ID 88-1032011
SIC Code 2844

Key Executives

Name Position
Kirk L. Perry Chief Executive Officer and Director
Meredith Stevens Chief Operations Officer
Amit Banati Chief Financial Officer
Heather R. Howlett Chief Accounting Officer
Michael Wondrasch Chief Technology and Data Officer
Dr. Caroline Tillett Ph.D. Chief Scientific Officer
Sofya Tsinis Head of Investor Relations
Matthew Orlando General Counsel
Jonathan Halvorson Chief Digital and Marketing Officer
Luani Alvarado Chief People Officer

Latest SEC Filings

Date Type Title
Feb 20, 2026 10-K Annual Report
Feb 17, 2026 8-K Current Report
Feb 17, 2026 SCHEDULE 13G/A Filing
Feb 12, 2026 8-K Current Report
Jan 29, 2026 8-K Current Report
Jan 27, 2026 425 Filing
Jan 16, 2026 425 Filing
Jan 16, 2026 425 Filing
Jan 16, 2026 8-K Current Report
Jan 16, 2026 425 Filing